# Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

> **NCT00730795** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Tuberculosis (TB)

## Interventions

- **BIOLOGICAL:** GSK's candidate Mycobacterium tuberculosis vaccine 692342

## Key facts

- **NCT ID:** NCT00730795
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2004-12
- **Final completion:** —
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2008-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00730795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00730795, "Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00730795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*